Home/Filings/4/0001493152-26-003078
4//SEC Filing

Williams Donald Allen 4

Accession 0001493152-26-003078

CIK 0001357459other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:05 PM ET

Size

5.4 KB

Accession

0001493152-26-003078

Research Summary

AI-generated summary of this filing

Updated

Palisade Bio (PALI) Director Donald Allen Buys 5,000 Shares

What Happened
Donald Allen, a director of Palisade Bio (PALI), made an open-market purchase of 5,000 shares on 2026-01-16 at $1.67 per share, for a total of $8,356. This was a purchase (Form 4 code P), which investors often view as a more informative signal than routine insider sales.

Key Details

  • Transaction date: 2026-01-16
  • Price: $1.67 per share; Shares purchased: 5,000; Total value: $8,356
  • Transaction type: Open-market purchase (Code P)
  • Form 4 filing date: 2026-01-21 — filed within the standard two business-day window (timely)
  • Shares owned after the transaction: Not specified in the provided filing excerpt
  • Footnotes/plans: No 10b5-1 plan, tax-withholding, or other special footnotes were reported in the provided excerpt

Context

  • Insider purchases can indicate confidence but are not proof of future stock performance.
  • The purchase size is modest (~$8.4k), so while it shows insider buying, it’s relatively small compared with larger insider or institutional transactions.

Insider Transaction Report

Form 4
Period: 2026-01-16
Transactions
  • Purchase

    Common Stock

    2026-01-16$1.67/sh+5,000$8,35610,728 total
Holdings
  • Common Stock

    (indirect: By Reporting Person's Defined Benefit Plan)
    3,000
Signature
/s/ Ryker Willie, Attorney-in-Fact|2026-01-21

Documents

1 file

Issuer

PALISADE BIO, INC.

CIK 0001357459

Entity typeother

Related Parties

1
  • filerCIK 0001620013

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:05 PM ET
Size
5.4 KB